Betulinic Acid and Brosimine B Hybrid Derivatives as Potential Agents against Female Cancers

Abstract

In this context, we showed that the combination of two complex structures generated the development of hybrids with differing inhibitory profiles and apoptotic modes of action, thus representing potential alternatives in female cancer treatment.